Amplifiable hybridization probes-molecules with a probe sequence embedded within the sequence of a replicatable RNA-wiIl promote the development of sensitive clinical assays. To demonstrate their utility, we prepared a recombinantRNA that containeda 30-nucleotide-longprobecomplementary to a conserved region of the pol gene in human immunodeficiency virus type 1 (HIV-1) mRNA. Test samples were prepared, each containing a different number of HIV-1 transcripts that served as simulated HIV-1 mRNA targets.
Suitable assays would make use of a macromolecular probe having extremely high affinity for a particular component of the infectious agent and very low affinity for all the other components of the sample. The highest specificities and most stable interactions known occur when a single-stranded oligonucleotide probe hybridizes to a com- However, the use of oligonucleotide probes is not sufficient to assure detection. An infected cell contains only about 6000 molecules of retroviral messenger RNA (3), so the problem becomes how to detect the probes once they are bound to such a small number of targets. The classic detection strategy is to attach reporter groups to the probes, such as fluorescent organic molecules or radioactive phosphate groups. More recently, biotin groups have been incorporated into probes (4). After the probes have bound to their targets, enzymes such as peroxidase or phosphatase are linked to the biotin, then incubated with a colorless substrate, leading to the accumulation of a large number of colored product molecules for each enzyme-probe adduct (5). However, the practical limit of detection of these schemes is about 106 target molecules. Clearly, they cannot be used to detect a single cell in a sample that contains only 6000 retroviral messenger RNAs.
A particularly attractive strategy for detecting rare targets is to link each probe to a replicatable reporter, which can be exponentially amplified after hybridization to reveal the presence of the probe (6). We recently described a novel version of this approach, in which a probe sequence was embedded within the sequence of a replicatable RNA (7). The resulting recombinant RNAs hybridize to their target sequences the same way as ordinary hybridization probes do and, as in a classical hybridization assay, nonhybridized probes are then washed away. The hybridized probes are then freed from their targets and released into solution. What makes these recombinant-RNA probes particularly useful is that they can then be exponentially amplified by incubation with the RNA-directed RNA polymerase, Q replicase (8). We have demonstrated that as many as 10 copies of each replicatable probe can be synthesized in a single 30-mm incubation (7) . Furthermore, the extreme specificity of Q13 replicase for its own template RNA (9) assures that only the replicatable probes will be amplified. The large number of copies synthesized can easily be quantified by incorporating radioactive nucleotides or by measuring the fluorescence of an intercalating dye such as ethidium bromide. Because as little as a single molecule of RNA can initiate exponential amplification (10), this approach offers the prospect of developing sensitive diagnostic assays.
Two developments led to our current work: the discovery that oligoribonucleotides can be inserted within the sequence of a small, naturally occurring template for Q/3 rephicase, MDV-1 RNA (11), without interfering with its rephicatability (12); and the availability of a plasmid that serves as a template for the synthesis of MDV-1(+) RNA when the plasmid is incubated in vitro with bacteriophage TI RNA polymerase. We modified this plasmid by inserting a polyhinker into the MDV-1 cDNA sequence. The subsequent insertion of a probe sequence within the polylinker creates a plasmid that serves as a template for the transcription of recombinant-RNA probes (7) . The site that we chose for inserting the polylinker and probe into MDV-1 RNA was known to be on the exterior of the molecule, where the presence of the inserted sequence was less likely to interfere with replication, and where the remainder of the molecule was less likely to interfere with the hybridization of the probe sequence to its target. In our previous report (7) , we demonstrated that these recombinant RNAs are bifunctional, in that they hybridize specifically to complementary target sequences and retain the ability to be exponentially amplified by Qj3 replicase. Here, we demonstrate the use of replicatable hybridization pr.obes in a model assay designed to detect very small amounts of H1V-1 mRNA. We had two main concerns in selecting the assay format: (a) because of the desirability of developing a method that can screen a large number of samples, the selected format had to be fast and simple, thus precluding the fractionation of cells or the isolation of nucleic acids; and (b) because nonhybridized probes are amplified by Q replicase along with hybridized probes, we needed an extremely efficient means of removing the nonhybridized probes. Our first problem was solved by the dual discoveries that hybridization is extremely efficient in solutions of the chaotropic salt, guanidine thiocyanate (13), and that concentrated solutions of guanidine thiocyanate will lyse cells, denature all proteins (including nucleases), liberate nucleic acids from cellular matrices, and unwind DNA molecules, permitting hybridization to occur without interference from cellular debris (3). Our second problem was solved by the development of the "reversible target We prepared recombinant RNAs containing a 30-nudeotide-long probe sequence complementary to a conserved region of the HJV-1 pol gene. We also prepared a set of serial dilutions of a stock solution of transcripts of the region of the H1V-1 genome that contains the pol gene, to simulate different amounts of HJV-1 mRNA that might be present in clinical samples. An excess of replicatable HIV-1 probes was added to each sample. After hybridization in the presence of guanidine thiocyanate, the probe-target hybrids were isolated by reversible target capture on paramagnetic particles. The probes were then released from their targets and exponentially amplified by incubation with Qf3 replicase. Samples of each reaction were taken every minute during replication. The amount of RNA in each sample was then measured. The results demonstrate how kinetic data can be used for quantitative determination of the number of target molecules in a sample. (17) , with the hydroxylapatite step omitted.
MaterIals and Methods

Enzymes and Oligodeoxyribonucleotides
Qj3 replicase is stable when stored in a glycerol solution at -20 #{176}C: its activity remains unchanged after five years of storage. Single-stranded DNA fragments were prepared, by using 3-cyanoethyl phosphoramidite chemistry, on a 380A synthesizer (Applied Biosystems, Foster City, CA).
ReplicatableHIV-1 Probes
Recombinant MDV-1 RNA containing an inserted H1V-1 probe sequence was synthesized by transcription from a recombinant plasmid. The plasmid was constructed by inserting a synthetic probe sequence (prepared by annealing dGATCACCGTAGCACTGGTGAAATFGCTGCCAT-TGA to dGATCTCAATGGCAGCAArI'TCACCAGTGC-TACGGT) into the Bgl II site of a plasmid that is identical to plasmid pT7-MDV-poly (7) , except that the polylinker sequence is in the opposite orientation.
The nucleotide sequence in the recombinant region of the cloned plasmid was confirmed by the chain termination
The synthesis of replicatable probes by transcription from linearized recombinant plasmids with P7 RNA polymerase is described in detail elsewhere ( 
ReversibleTarget Capture
After the completion of hybridization, the probe-target hybrids were isolated from the reaction mixture by binding them to oligo(dT) groups on the surface of parainagnetic particles (14). These ferric oxide particles (<1 m in diameter), purchased from Gene-Trak Systems, possess highly convoluted surfaces coated with silicon hydrides to which numerous oligo(dT) "hairs" have been covalently linked. We added 50 L of a suspension of paramagnetic particles to each reaction tube, reducing the guanidine thiocyanate Because the particles are paramagnetic, they do not act as magnets, and they do not cling to each other. However, when placed in a magnetic field, they are drawn to the magnetic source. Accordingly, the paramagnetic particles, with the probe-target hybrids bound to their surface, were drawn to the walls of the titertubes by placing the tubes in the presence of the strong magnetic field provided by a magnetic separation device (purchased from Gene-Trak Systems). The supernates, which contained the nonhybridized probes, were then withdrawn from each tube by aspiration, and replaced by 200 L of a wash solution containing GuSCN at 1.5 mol/L. The tubes were then withdrawn from the magnetic field, and the probe-target target sequence forthe capture probe islocated relatively close to the target sequence forthe replicatableprobe onthe target molecule. The capture probe also contains a 3'.poly(dA) tail that is hybridizedto an oligo(dT) group on the surfaceof the paramagneticparticle.The hybridformed by the 3'-poly(dA) tall and the oligo(dT) group is relatively weak, permitting the more stable probe-target hybridto be released from theparticle at higherconcentrations of guanidinethiocyanate (14) hybrids attached to the resuspended particles were washed by vigorous agitation on a multi-tube vortex-type mixer (American Hospital Supply, McGaw Park, IL). The particles were again drawn to the walls of the tubes, the supernates were aspirated, another 200 jzL of 1.5 moIJL GuSCN wash solution was added, and the particles were again agitated and drawn to the walls of the tubes. The supernates were again withdrawn by aspiration, but this time they were replaced with 50 L of a release solution containing 3.25 mol of GuSCN per liter.
The tubes were again removed from the magnetic field, agitated to resuspend the particles, and then incubated at 37#{176}C for 5 mm. In this more-concentrated GuSCN solution, the relatively weak hybrids formed between the 3'-poly(dA) tails of the capture probes and the oligo(dT) groups on the surface of the particles came apart, releasing the probe-target hybrids back into solution. However, the much stronger hybrids formed between the capture probes and the target (and between the replicatable probe and the target) remained intact (14). The stripped particles were then drawn to the sides of the tubes, and the supernates (containing the released probe-target hybrids) were transferred to new tubes. The stripped particles were discarded and 50 L of a suspension of fresh particles was added to each new tube, reducing the GuSCN concentration to 1.62 molIL. The tubes were incubated at 37 #{176}C for 10 mm to allow the probe-target hybrids to be recaptured by the hybridization of the 3'-poly(dA) tails of the capture probes The membrane was then air-dried, and the amount of E32PIRNA present in each sample on the membrane was made visible by autoradiography. After the autoradiograph was prepared, the amount of RNA present in each dot-blot was measured in a scintillation counter.
Results
We carried out model assays in which replicatable H1V-1 probes were hybridized to serial dilutions of simulated mV-i mRNA target molecules in the presence of guamdine thiocyanate (13). After hybridization, the resulting probe-target hybrids were isolated by three cycles of reversible target capture (14) on paramagnetic particles. The hybridized probes were then released from their targets and exponentially amplified by incubation with Q replicase (7) , with samples of each reaction being taken at 1-min intervals. Electrophoretic analysis of the size and homogeneity of the RNA in each sample indicated that only MDV-hiv RNA was synthesized.
An aliquot of each sample was bound to a nylon membrane in a dot-blot filtration apparatus, and the [32P]MDVhiv RNA in each aliquot was made visible by autoradiography. In the resulting autoradiogram (Figure 3) , the density of each spot indicated the amount of RNA present at each time point. After the autoradiogram was prepared, the amount of RNA in each sample was measured with a scintillation counter. Although no RNA was apparent in the early time points, this was the period in which the RNA population increased exponentially (8). The RNA became visible in the autoradiogram at about the same time that the number of RNA molecules equaled the number of active replicase molecules (the "saturation point"). From that time on, the RNA population increased linearly (23) . Thus, at those times when the RNA was visible in each reaction, the ENA population was increasing linearly. The results demonstrate that the time at which the saturation point occurs in each amplification reaction is a function of the number of target molecules originally present in the corresponding hybridization reaction. The fewer target molecules that were originally present, the fewer the replicatable probes that were bound to targets, and thus the fewer replicatable probes that were available to initiate the amplification reaction. Because amplification reactions initiated with fewer replicatable probes must undergo more I #{149} I ",.
4
-:.! #{149}..#{149} Fig. 3 . Kinetic analysis of amplification reactions initiated with replicatable probes isolated fromhybridization reactions Approximately50 ng of MDV-hiv RNA was synthesized in each amplification reaction. This amount of RNA is sufficient to have been accurately measured by the fluorescence of an intercalating dye, such as ethidlum bromide doublings of the RNA population before there are enough RNA molecules to achieve saturation, the kinetic data can be used to calculate the number of replicatable probes that were present at the beginning of the reaction. If known standards are included among the unknown samples to be tested, then these data can be used to determine the number of target molecules originally present in each unknown sample. The results also indicate the limit of detection. The amplification reaction corresponding to the sample containing 10 targets achieved saturation at an earlier time than did the amplification reaction corresponding to the sample containing i0 targets. However, there was no significant difference in the amplification reactions corresponding to the samples containing 10 and iO targets. Accordingly, the limit of detection was about 10000 target molecules. Because electrophoretic analysis of the amplified RNA in each sample indicated that only recombinant RNA was synthesized, the limit of detection was determined by the level of persistence of nonhybridized replicatable probes. It is important to note that these were only preliminary assays, designed to demonstrate how replicatable probes might be used. Further experiments should lead to alterations in the assay format that will improve the sensitivity.
DIscussion
During exponential synthesis, the time it takes for the RNA population to double is a constant for a given set of reaction conditions (23). If we know how many replicatable probes were initially present in a reaction, and if we know how long that reaction was incubated, then we can predict how many doublings have occurred and how many RNA molecules have been synthesized. Conversely, if we know how long it takes for a particular number of RNA molecules to be synthesized, then we can calculate how many molecules of replicatable probe were present initially. This relationship is summarized by the following equation:
where N0 is the initial number of RNA molecules; t is the time of incubation; d is the characteristic time it takes for the RNA population to double; and N is the number of RNA molecules present at time t. Taking the logarithm of each side of the equation and rearranging algebraically:
where (-log 2)/d is a constant. If we consider the situation that occurs when we determine the time it takes for each reaction to synthesize a particular number of RNA molecules, then log N will also be a constant and twill represent the time it takes for the RNA population to grow to N molecules. There will then be an inverse linear relationship between t and log N0. Therefore, if we have a reliable method for determining the time it takes for an exponentially replicating RNA population to grow to a particular (though arbitrary) number of molecules, then we can accurately determine the initial number of replicatable probes.
There is a good method for determining how long it takes for a particular number of RNA molecules to be synthesized. An intercalating fluorescent dye, such as ethidium bromide, could be included in the RNA amplification reaction mixture. Ethidium bromide becomes fluorescent when it interacts with the secondary structures present in replicatable probes. An ethidium bromide concentration of about 1 pmoll L would give a good signal, without significantly inhibiting replication (23) .
A simple instrument could periodically monitor the fluorescence of the ethidium bromide in an entire set of amplification reactions. Initially, the number of RNA molecules would be too low to produce an appreciable fluorescence. However, as exponential synthesis proceeds, the fluorescence would increase. The instrument would be programmed to store the kinetic data and to use these data to determine the time for each reaction at which the fluerescence corresponds to the presence of a particular number of RNA molecules (the "endpoint").
The inclusion of standards in the hybridization reaction, each containing a known number of target molecules, would permit the establishment of a "standard curve," in which the logarithm of the number of target molecules would be inversely proportional to the time at which the endpoint is reached (as described in the second equation). The number of target molecules in each of the unknown samples would then be determined by comparing their endpoints with those on the standard curve. This method is readily automatable; it would not require radioactive compounds; the magnitude of the fluorescent signal at the endpoint would be the same for all the reactions and would be well above the fluorescent background; the assay would be accurate; and the logarithmic nature of the standard curve would permit the determination of the number of targets in a sample over an extremely wide range of target concentrations.
There is an alternative method for analyzing the data. Once the saturation point is reached in an amplification reaction, the number of RNA molecules increases linearly with time. For example, in Figure 3 , by the time the reactions had been incubated for 28 mm, they had all passed the saturation point and were in the linear phase of synthesis. A comparison of the amounts of RNA present in each sample at 28 mm shows that the most RNA is present in those samples that correspond to the hybridization reactions that contained the most targets. Because these reactions were initiated with the greatest number of replicatable probes, they reached the saturation point soonest and had the longest period of time to synthesize RNA in the linear phase. We can analyze the data by using the direct linear relationship between the amount of RNA present at a particular (though arbitrary) time in the linear phase and the logarithm of the number of replicatable probes that initiate a reaction (7) . If known standards are included among the unknown samples to be tested, then these data can be used to determine the number of target molecules present in each unknown sample. Because it is relatively simple to devise an assay kit to measure the amount of RNA synthesized in a reaction that is incubated for a fixed length of time, this alternative analytical approach would be an inexpensive method for detecting infectious agents in the field.
The model assay we have described demonstrates that replicatable hybridization probes can be used in quantitative assays designed to detect rare targets. Further experiments will be needed to develop actual clinical assays for measuring the number of 11W-i mENA molecules in blood samples. However, it is clear that these assays will be simple, accurate, sensitive, and automatable.
